Glecirasib (JAB-21822) is an orally active KRAS G12C inhibitor that selectively binds to and inhibits the activity of KRAS G12C mutants, thereby inhibiting KRAS G12C-dependent signaling. In animal models, KRAS G12C inhibitor 36 showed a favorable safety profile and potential to inhibit tumor growth.
Molecular Weight:
640.03
Purity:
>99.99%
CAS Number:
[2657613-87-9]
Formula:
C31H26ClF4N7O2
Target:
Ras|||Kras
T78651
T78651
* VAT and and shipping costs not included. Errors and price changes excepted